Celanese Co.

Celanese has signed a definitive agreement to sell a further 19% stake in Nutrinova to Mitsui for about $152 million, reducing Celanese’s stake to 11%. The sold stake generated an equity result of roughly $4 million in 2025. Proceeds will be used to reduce net debt and pay down upcoming liabilities; closing is expected in Q4 2026 and is subject to customary regulatory conditions. Celanese will temporarily continue to operate a diketene production facility in Höchst, which will then be transferred to Nutrinova; Nutrinova will reimburse the purchase price and assume ongoing costs. » Mais em de.investing.com

Turtle Creek highlighted Celanese as having a competitive advantage because its production disproportionately uses low-cost U.S. natural gas, helping generate significant free cash flow despite weaker-than-expected EBITDA and EPS in Q1 2026. Celanese closed at $51.23 on June 17, 2026, with a one-month return of -3.16% and a 52-week loss of 5.81%, and a market cap of $5.62 billion. Hedge fund ownership rose to 49 portfolios at quarter-end from 42 the prior quarter. » Mais em finance.yahoo.com

Celanese has halted manufacturing at its technical materials plant in Ulsan with immediate effect and is shifting volumes to Nanjing and Shenzhen in China and to Silvassa in India. The company said it will contractually support customers during the transition; the move is part of a production-network optimization to cut costs. Celanese produces materials such as PET, PA, PBT and HTN, reported net sales of $9.5 billion in 2025 and employs around 11,000 people. » Mais em de.investing.com

Celanese narrowly missed expectations in Q1 with adjusted earnings of $0.85 per share but presented a turnaround strategy. Management forecasts adjusted EBIT of $300–325 million for the Acetyl Chain in Q2, implying a significant sequential increase from Q1, and guides adjusted earnings per share of $2.00–2.40 for Q2. The company also raised its 2026 free-cash-flow target to $700–800 million, announced restructurings in the nylon platform and extensive cost-cutting measures. Despite the near-term improvements, a cautious outlook for the second half put pressure on the stock. » Mais em de.investing.com

Celanese reported Q1 EPS of $0.85 (expected $0.86) on revenue of $2.34 billion, with revenue meeting forecasts while earnings came in slightly below. The stock fell 9.63% after the close but recovered about 2% in premarket trading. The company expects about $200 million of improvement in the acetyl‑chain business in Q2 and plans cost cuts in nylon 6,6 (target: $30 million). Celanese sees significantly higher profitability and EBITDA growth in the second half of the year, but continues to cite geopolitically driven supply‑chain disruptions and weak demand as risks. » Mais em de.investing.com